Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. As previously reported, on May 20, 2024, GRI Bio, Inc. (the “Company”) entered into an At The Market Offering Agreem
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 10.1 Amendment No. 1